The DOI matches its Crossref record; 505 of the 505 references it cites were found in a registry or an index.
Diabetic kidney disease
Open accessAbstract
The kidney is arguably the most important target of microvascular damage in diabetes. A substantial proportion of individuals with diabetes will develop kidney disease owing to their disease and/or other co-morbidity, including hypertension and ageing-related nephron loss. The presence and severity of chronic kidney disease (CKD) identify individuals who are at increased risk of adverse health outcomes and premature mortality. Consequently, preventing and managing CKD in patients with diabetes is now a key aim of their overall management. Intensive management of patients with diabetes includes controlling blood glucose levels and blood pressure as well as blockade of the renin–angiotensin–aldosterone system; these approaches will reduce the incidence of diabetic kidney disease and slow its progression. Indeed, the major decline in the incidence of diabetic kidney disease (DKD) over the past 30 years and improved patient prognosis are largely attributable to improved diabetes care. However, there remains an unmet need for innovative treatment strategies to prevent, arrest, treat and reverse DKD. In this Primer, we summarize what is now known about the molecular pathogenesis of CKD in patients with diabetes and the key pathways and targets implicated in its progression. In addition, we discuss the current evidence for the prevention and management of DKD as well as the many controversies. Finally, we explore the opportunities to develop new interventions through urgently needed investment in dedicated and focused research. For an illustrated summary of this Primer, visit: http://go.nature.com/NKHDzg
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 505
Rudberg, S., Persson, B., & Dahlquist, G. (1992) · Kidney International · doi:10.1038/ki.1992.126 · Cited by 296
Groop, P.-H., Cooper, M. E., Perkovic, V., Emser, A., Woerle, H.-J., & von Eynatten, M. (2013) · Diabetes Care · doi:10.2337/dc13-0323 · Cited by 294
Self-citationAdvanced glycation end products: A nephrologist's perspective
Raj, D. S. C., Choudhury, D., Welbourne, T. C., & Levi, M. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70189-2 · Cited by 290
Zhang, Z., Zhang, Y., Ning, G., Deb, D. K., Kong, J., & Li, Y. C. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803751105 · Cited by 289
Urinary Proteomics in Diabetes and CKD
Rossing, K., Mischak, H., Dakna, M., Zürbig, P., Novak, J., Julian, B. A., Good, D. M., Coon, J. J., Tarnow, L., & Rossing, P. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2007091025 · Cited by 283
Self-citationEffects of Antioxidants in Diabetes-Induced Oxidative Stress in the Glomeruli of Diabetic Rats
Koya, D., Hayashi, K., Kitada, M., Kashiwagi, A., Kikkawa, R., & Haneda, M. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077412.07578.44 · Cited by 279
Chow, F. Y., Nikolic-Paterson, D. J., Ozols, E., Atkins, R. C., & Tesch, G. H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2004070612 · Cited by 277
Krolewski, A. S., Niewczas, M. A., Skupien, J., Gohda, T., Smiles, A., Eckfeldt, J. H., Doria, A., & Warram, J. H. (2014) · Diabetes Care · doi:10.2337/dc13-0985 · Cited by 276
Incidence of End-stage Renal Disease in Patients With Type 1 Diabetes
Finne, P. (2005) · JAMA · doi:10.1001/jama.294.14.1782 · Cited by 273
Brancati, F. L. (1997) · JAMA · doi:10.1001/jama.278.23.2069 · Cited by 272
Lowering Blood Pressure Reduces Renal Events in Type 2 Diabetes
de Galan, B. E., Perkovic, V., Ninomiya, T., Pillai, A., Patel, A., Cass, A., Neal, B., Poulter, N., Harrap, S., Mogensen, C.-E., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008070667 · Cited by 271
Self-citationShurraw, S. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.537 · Cited by 269
Chalmers, J., & Cooper, M. E. (2008) · New England Journal of Medicine · doi:10.1056/nejme0807625 · Cited by 263
Self-citationBomback, A. S., Kshirsagar, A. V., Amamoo, M. A., & Klemmer, P. J. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.10.040 · Cited by 261
Impaired Tubular Uptake Explains Albuminuria in Early Diabetic Nephropathy
Russo, L. M., Sandoval, R. M., Campos, S. B., Molitoris, B. A., Comper, W. D., & Brown, D. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008050503 · Cited by 261
Antiproteinuric effect of blood-pressure-lowering agents: a meta-analysis of comparative trials
Gansevoort, R. T., Sluiter, W. J., Hemmelder, M. H., de Zeeuw, D., & de Jong, P. E. (1995) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/10.11.1963 · Cited by 259
Glomerular size and structure in diabetes mellitus. II. Late abnormalities
Gundersen, H. J. G., & �sterby, R. (1977) · Diabetologia · doi:10.1007/bf00996326 · Cited by 256
de Boer, I. H., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2113 · Cited by 254
Williams, M. E., Bolton, W. K., Khalifah, R. G., Degenhardt, T. P., Schotzinger, R. J., & McGill, J. B. (2007) · American Journal of Nephrology · doi:10.1159/000108104 · Cited by 253
Evaluating the Role of Epigenetic Histone Modifications in the Metabolic Memory of Type 1 Diabetes
Miao, F., Chen, Z., Genuth, S., Paterson, A., Zhang, L., Wu, X., Li, S. M., Cleary, P., Riggs, A., Harlan, D. M., et al. (2014) · Diabetes · doi:10.2337/db13-1251 · Cited by 253
Bilous, R., Chaturvedi, N., Sjølie, A. K., Fuller, J., Klein, R., Orchard, T., Porta, M., & Parving, H.-H. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-151-1-200907070-00120 · Cited by 252
The Diabetes Control and Complications Trial Research Group (1997) · Diabetes · doi:10.2337/diab.46.11.1829 · Cited by 249
Wang, B., Herman-Edelstein, M., Koh, P., Burns, W., Jandeleit-Dahm, K., Watson, A., Saleem, M., Goodall, G. J., Twigg, S. M., Cooper, M. E., et al. (2010) · Diabetes · doi:10.2337/db09-1736 · Cited by 244
Self-citationRenal disease and hypertension in non–insulin-dependent diabetes mellitus
Ismail, N., Becker, B., Strzelczyk, P., & Ritz, E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.00232.x · Cited by 242
Orchard, T. J., Chang, Y.-F., Ferrell, R. E., Petro, N., & Ellis, D. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00507.x · Cited by 239
Wadén, J., Forsblom, C., Thorn, L. M., Gordin, D., Saraheimo, M., Groop, P.-H., & on behalf of the Finnish Diabetic Nephropathy Study Group (2009) · Diabetes · doi:10.2337/db09-0693 · Cited by 239
Self-citationNavarro, J. F., Mora, C., Macıéa, M., & Garcıéa, J. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00408-6 · Cited by 238
Breyer, J. A., Bain, R. P., Evans, J. K., Nahman, N. S., Lewis, E. J., Cooper, M., McGill, J., Berl, T., & The Collaborative Study Group (1996) · Kidney International · doi:10.1038/ki.1996.481 · Cited by 234
Self-citationGroop, L., Ekstrand, A., Forsblom, C., Wid�n, E., Groop, P. H., Teppo, A. M., & Eriksson, J. (1993) · Diabetologia · doi:10.1007/bf00404074 · Cited by 234
Self-citationThe intrarenal renin–angiotensin system and diabetic nephropathy
Carey, R. M., & Siragy, H. M. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/s1043-2760(03)00111-5 · Cited by 230
Lacourcière, Y., Bélanger, A., Godin, C., Hallé, J.-P., Ross, S., Wright, N., & Marion, J. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00224.x · Cited by 229
R., L., D., K., A., C., N., T., H., H., P., Z., N., P., D., C., & R., G. (2002) · Diabetologia · doi:10.1007/s00125-002-0946-y · Cited by 228
Diabetic nephropathy: Prevention and treatment
Parving, H.-H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00020.x · Cited by 226
Yokoyama, H., Okudaira, M., Otani, T., Sato, A., Miura, J., Takaike, H., Yamada, H., Muto, K., Uchigata, Y., Ohashi, Y., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00166.x · Cited by 226
Ko, Y.-A., Mohtat, D., Suzuki, M., Park, A. S. D., Izquierdo, M. C., Han, S. Y., Kang, H. M., Si, H., Hostetter, T., Pullman, J. M., et al. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r108 · Cited by 225
Rossing, K., Jacobsen, P., Pietraszek, L., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2268 · Cited by 225
Glomerular hyperfiltration: a marker of early renal damage in pre-diabetes and pre-hypertension
Palatini, P. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs037 · Cited by 224
Pignone, M., Alberts, M. J., Colwell, J. A., Cushman, M., Inzucchi, S. E., Mukherjee, D., Rosenson, R. S., Williams, C. D., Wilson, P. W., & Kirkman, M. S. (2010) · Circulation · doi:10.1161/cir.0b013e3181e3b133 · Cited by 223
Environmentally induced epigenetic transgenerational inheritance of phenotype and disease
Guerrero-Bosagna, C., & Skinner, M. K. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.004 · Cited by 222
Therapeutic potential of breakers of advanced glycation end product–protein crosslinks
Vasan, S., Foiles, P., & Founds, H. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2003.08.016 · Cited by 221
Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
Krolewski, A. S. (2015) · Diabetes Care · doi:10.2337/dc15-0184 · Cited by 220
Bakker, A. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.2.307 · Cited by 220
High Glucose Inhibits Glucose-6-phosphate Dehydrogenase via cAMP in Aortic Endothelial Cells
Zhang, Z., Apse, K., Pang, J., & Stanton, R. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007505200 · Cited by 220
Szczech, L. A., Best, P. J., Crowley, E., Brooks, M. M., Berger, P. B., Bittner, V., Gersh, B. J., Jones, R., Califf, R. M., Ting, H. H., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016051.33225.33 · Cited by 220
Hoy, W. E., Mathews, J. D., Mccredie, D. A., Pugsley, D. J., Hayhurst, B. G., Rees, M., Kile, E., Walker, K. A., & Wang, Z. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00099.x · Cited by 220
Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria.
Lebovitz, H. E., Wiegmann, T. B., Cnaan, A., Shahinfar, S., Sica, D. A., Broadstone, V. L., Schwartz, S. L., Mengel, M. C., Segal, R., & Versaggi, J. A. (1994) · PubMed · Cited by 219
Parving, H.-H., Smidt, U. M., Friisberg, B., Bonnevie-Nielsen, V., & Andersen, A. R. (1981) · Diabetologia · doi:10.1007/bf00253407 · Cited by 217
Lipoproteins in the DCCT/EDIC cohort: Associations with diabetic nephropathy
Jenkins, A. J., Lyons, T. J., Zheng, D., Otvos, J. D., Lackland, D. T., Mcgee, D., Timothy Garvey, W., Klein, R. L., & The DCCT/EDIC Research Group (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00164.x · Cited by 214
Thomas, M. C., MacIsaac, R. J., Jerums, G., Weekes, A., Moran, J., Shaw, J. E., & Atkins, R. C. (2009) · Diabetes Care · doi:10.2337/dc08-2186 · Cited by 214
Self-citationEpigenetics: Mechanisms and Implications for Diabetic Complications
Cooper, M. E., & El-Osta, A. (2010) · Circulation Research · doi:10.1161/circresaha.110.223552 · Cited by 213
Self-citationDefective intracellular antioxidant enzyme production in type 1 diabetic patients with nephropathy.
Ceriello, A., Morocutti, A., Mercuri, F., Quagliaro, L., Moro, M., Damante, G., & Viberti, G. C. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2170 · Cited by 210
Renal handling of albumin: A critical review of basic concepts and perspective
Russo, L. M., Bakris, G. L., & Comper, W. D. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32764 · Cited by 209
Jacobsen, P., Andersen, S., Jensen, B. R., & Parving, H.-H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000054495.96193.bf · Cited by 209
Quantitation of Proteinuria by the Use of Protein-to-Creatinine Ratios in Single Urine Samples
Schwab, S. J. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370050135022 · Cited by 208
The Consequences of Tubulo-Interstitial Changes for Renal Function in Glomerulopathies
Bohle, A., Mackensen-Haen, S., von Gise, H., Grund, K.-E., Wehrmann, M., Batz, C., Bogenschütz, O., Schmitt, H., Nagy, J., Müller, C., et al. (1990) · Pathology - Research and Practice · doi:10.1016/s0344-0338(11)81021-6 · Cited by 204
Diabetic nephropathy--a review of the natural history, burden, risk factors and treatment.
Ayodele, O. E., Alebiosu, C. O., & Salako, B. L. (2004) · PubMed · Cited by 203
Kshirsagar, A. V., Joy, M. S., Hogan, S. L., Falk, R. J., & Colindres, R. E. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70018-7 · Cited by 203
PPARα agonist fenofibrate improves diabetic nephropathy in db/db mice
Park, C. W., Zhang, Y., Zhang, X., Wu, J., Chen, L., Cha, D. R., Su, D., Hwang, M.-T., Fan, X., Davis, L., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5000209 · Cited by 202
Effect of Thiazolidinediones on Albuminuria and Proteinuria in Diabetes: A Meta-analysis
Sarafidis, P. A., Stafylas, P. C., Georgianos, P. I., Saratzis, A. N., & Lasaridis, A. N. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.013 · Cited by 197
Prevention and Treatment of Diabetic Renal Disease in Type 2 Diabetes: The BENEDICT Study
Remuzzi, G., Macia, M., & Ruggenenti, P. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005121324 · Cited by 194
Comparison of different measures of urinary protein excretion for prediction of renal events
Lambers Heerspink, H. J., Gansevoort, R. T., Brenner, B. M., Cooper, M. E., Parving, H. H., Shahinfar, S., & de Zeeuw, D. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010010063 · Cited by 193
Self-citationEndothelin A Receptor Blockade Reduces Diabetic Renal Injury via an Anti-Inflammatory Mechanism
Sasser, J. M., Sullivan, J. C., Hobbs, J. L., Yamamoto, T., Pollock, D. M., Carmines, P. K., & Pollock, J. S. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006030208 · Cited by 193
Systematic review on urine albumin testing for early detection of diabetic complications
Newman, D., Mattock, M., Dawnay, A., Kerry, S., McGuire, A., Yaqoob, M., Hitman, G., & Hawke, C. (2005) · Health Technology Assessment · doi:10.3310/hta9300 · Cited by 192
Renoprotection: One or many therapies?
Hebert, L. A., Wilmer, W. A., Falkenhain, M. E., Ladson-Wofford, S. E., Nahman, N. S., & Rovin, B. H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.0590041211.x · Cited by 191
Effects of Fibrates in Kidney Disease
Jun, M., Zhu, B., Tonelli, M., Jardine, M. J., Patel, A., Neal, B., Liyanage, T., Keech, A., Cass, A., & Perkovic, V. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.049 · Cited by 189
Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus
Yoshida, H., Kuriyama, S., Atsumi, Y., Tomonari, H., Mitarai, T., Hamaguchi, A., Kubo, H., Kawaguchi, Y., Kon, V., Matsuoka, K., et al. (1996) · Kidney International · doi:10.1038/ki.1996.362 · Cited by 189
Poulsen, P. L., Hansen, K. W., & Mogensen, C. E. (1994) · Diabetes · doi:10.2337/diab.43.10.1248 · Cited by 189
Insulin Resistance and Microalbuminuria
Parvanova, A. I., Trevisan, R., Iliev, I. P., Dimitrov, B. D., Vedovato, M., Tiengo, A., Remuzzi, G., & Ruggenenti, P. (2006) · Diabetes · doi:10.2337/db05-1484 · Cited by 189
Long-term renal effects of a neutralizing RAGE antibody in obese type 2 diabetic mice
Flyvbjerg, A., Denner, L., Schrijvers, B. F., Tilton, R. G., Mogensen, T. H., Paludan, S. R., & Rasch, R. (2004) · Diabetes · doi:10.2337/diabetes.53.1.166 · Cited by 187
RUGGENENTI, P., PERNA, A., BENINI, R., BERTANI, T., ZOCCALI, C., MAGGIORE, Q., SALVADORI, M., & REMUZZI, G. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v105997 · Cited by 186
Bash, L. D., Selvin, E., Steffes, M., Coresh, J., & Astor, B. C. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.22.2440 · Cited by 186
Meikle, P. J., Wong, G., Barlow, C. K., & Kingwell, B. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.001 · Cited by 184
Wnt/β-Catenin Pathway in Podocytes Integrates Cell Adhesion, Differentiation, and Survival
Kato, H., Gruenwald, A., Suh, J. H., Miner, J. H., Barisoni-Thomas, L., Taketo, M. M., Faul, C., Millar, S. E., Holzman, L. B., & Susztak, K. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.223164 · Cited by 183
Self-citationBroadening the Spectrum of Diseases Related to Podocin Mutations
Caridi, G., Bertelli, R., Di Duca, M., Dagnino, M., Emma, F., Onetti Muda, A., Scolari, F., Miglietti, N., Mazzucco, G., Murer, L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000060578.79050.e0 · Cited by 183
Groop, P.-H., Forsblom, C., & Thomas, M. C. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0046 · Cited by 182
Self-citationEffect of intensive blood pressure control on the course of type 1 diabetic nephropathy
Lewis, J. B., Berl, T., Bain, R. P., Rohde, R. D., & Lewis, E. J. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70036-3 · Cited by 181
Distinguishing Hyperglycemic Changes by Set7 in Vascular Endothelial Cells
Okabe, J., Orlowski, C., Balcerczyk, A., Tikellis, C., Thomas, M. C., Cooper, M. E., & El-Osta, A. (2012) · Circulation Research · doi:10.1161/circresaha.112.266171 · Cited by 180
Self-citationACE Inhibitors Improve Diabetic Nephropathy Through Suppression of Renal MCP-1
Amann, B., Tinzmann, R., & Angelkort, B. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2421 · Cited by 179
Diabetic Nephropathy: Can Renoprotection Be Extrapolated to Cardiovascular Protection?
Opie, L. H., & Parving, H.-H. (2002) · Circulation · doi:10.1161/01.cir.0000028099.24188.c4 · Cited by 178
Effects of Lowering LDL Cholesterol on Progression of Kidney Disease
Haynes, R., Lewis, D., Emberson, J., Reith, C., Agodoa, L., Cass, A., Craig, J. C., de Zeeuw, D., Feldt-Rasmussen, B., Fellström, B., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013090965 · Cited by 176
Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials
Pan, Y., Guo, L. L., & Jin, H. M. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/88.3.660 · Cited by 174
Sturrock, N. D. C., George, E., Pound, N., Stevenson, J., Peck, G. M., & Sowter, H. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00284.x · Cited by 172
Alderson, N. L., Chachich, M. E., Youssef, N. N., Beattie, R. J., Nachtigal, M., Thorpe, S. R., & Baynes, J. W. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00027.x · Cited by 171
Burrows, N. R., Li, Y., & Geiss, L. S. (2009) · Diabetes Care · doi:10.2337/dc09-0343 · Cited by 170
Prevention of End-Stage Renal Disease Due to Type 2 Diabetes
Hostetter, T. H. (2001) · New England Journal of Medicine · doi:10.1056/nejm200109203451209 · Cited by 169
The link between obesity and albuminuria: adiponectin and podocyte dysfunction
Sharma, K. (2009) · Kidney International · doi:10.1038/ki.2009.137 · Cited by 168
Self-citationPenno, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Zerbini, G., Morano, S., Cavalot, F., Lamacchia, O., Laviola, L., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2264 · Cited by 168
de Zeeuw, D., Anzalone, D. A., Cain, V. A., Cressman, M. D., Heerspink, H. J. L., Molitoris, B. A., Monyak, J. T., Parving, H.-H., Remuzzi, G., Sowers, J. R., et al. (2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70246-3 · Cited by 167
Pirfenidone Is Renoprotective in Diabetic Kidney Disease
RamachandraRao, S. P., Zhu, Y., Ravasi, T., McGowan, T. A., Toh, I., Dunn, S. R., Okada, S., Shaw, M. A., & Sharma, K. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008090931 · Cited by 167
Self-citationGlomerular size and structure in diabetes mellitus: I. Early abnormalities
�sterby, R., & Gundersen, H. J. G. (1975) · Diabetologia · doi:10.1007/bf00422326 · Cited by 167
Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy
Kanamori, H., Matsubara, T., Mima, A., Sumi, E., Nagai, K., Takahashi, T., Abe, H., Iehara, N., Fukatsu, A., Okamoto, H., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.06.148 · Cited by 166
Updating the natural history of diabetic nephropathy
Pugliese, G. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0650-7 · Cited by 165
Bakris, G., Burgess, E., Weir, M., Davidai, G., & Koval, S. (2008) · Kidney International · doi:10.1038/ki.2008.204 · Cited by 162
Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration.
Forsblom, C. M., Groop, P. H., Ekstrand, A., & Groop, L. C. (1992) · BMJ · doi:10.1136/bmj.305.6861.1051 · Cited by 162
Self-citationStructural involvement in type 1 and type 2 diabetic nephropathy.
Vestra, M. D., Saller, A., Bortoloso, E., Mauer, M. S., & Fioretto, P. (2000) · PubMed · Cited by 160
Lundbæk, K. (1954) · The Lancet · doi:10.1016/s0140-6736(54)90924-1 · Cited by 160
Penno, G., Chaturvedi, N., Talmud, P. J., Cotroneo, P., Manto, A., Nannipieri, M., Luong, L. A., & Fuller, J. H. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1507 · Cited by 159
Dwyer, J. P., Parving, H., Hunsicker, L. G., Ravid, M., Remuzzi, G., Lewis, J. B., & for the DEMAND Investigators (2011) · Cardiorenal Medicine · doi:10.1159/000333249 · Cited by 155
Caramori, M. L., & Mauer, M. S. (2003) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200305000-00008 · Cited by 155
Comprehensive clinical nephrology
Feehally, J., Floege, J., & Johnson, R. J. (2015) · Cited by 150
Birth Weight and Renal Disease in Pima Indians with Type 2 Diabetes Mellitus
Nelson, R. G., Morgenstem, H., & Bennett, P. H. (1998) · American Journal of Epidemiology · doi:10.1093/aje/148.7.650 · Cited by 147
Nowak, N., SKUPIEN, J. K., Niewczas, M. A., Yamanouchi, M., Major, M., Croall, S., Smiles, A. M., Warram, J. H., Bonventre, J. V., & Królewski, A. S. (2015) · Kidney International · doi:10.1038/ki.2015.314 · Cited by 145
Schaffer, S. W., Jong, C. J., & Mozaffari, M. S. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.03.005 · Cited by 143
A urinary peptide biomarker set predicts worsening of albuminuria in type 2 diabetes mellitus
Roscioni, S. S., de Zeeuw, D., Hellemons, M. E., Mischak, H., Zürbig, P., Bakker, S. J. L., Gansevoort, R. T., Reinhard, H., Persson, F., Lajer, M., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2755-2 · Cited by 143
Self-citationCardiovascular and Renal Outcomes With Telmisartan, Ramipril, or Both in People at High Renal Risk
Tobe, S. W., Clase, C. M., Gao, P., McQueen, M., Grosshennig, A., Wang, X., Teo, K. K., Yusuf, S., & Mann, J. F. E. (2011) · Circulation · doi:10.1161/circulationaha.110.964171 · Cited by 140
9. Microvascular Complications and Foot Care
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s012 · Cited by 137
Prediction of Kidney-Related Outcomes in Patients With Type 2 Diabetes
Jardine, M., Hata, J., Woodward, M., Perkovic, V., Ninomiya, T., Arima, H., Zoungas, S., Cass, A., Patel, A. A., Marre, M., et al. (2012) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2012.04.025 · Cited by 136
Self-citationGenetics of Kidneys in Diabetes (GoKinD) Study
Mueller, P. W., Rogus, J. J., Cleary, P. A., Zhao, Y., Smiles, A. M., Steffes, M. W., Bucksa, J. M., Gibson, T. B., Cordovado, S. K., Królewski, A. S., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005080822 · Cited by 134
Secondary Hyperparathyroidism: Pathophysiology and Treatment
Saliba, W., & El-Haddad, B. (2009) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.2009.05.090026 · Cited by 133
Bellizzi, V., Iorio, B. R. D., Nicola, L. D., Minutolo, R., Zamboli, P., Trucillo, P., Catapano, F., Cristofano, C. D., Scalfi, L., Conte, G., et al. (2006) · Kidney International · doi:10.1038/sj.ki.5001955 · Cited by 133
The potential for renoprotection with incretin-based drugs
Tanaka, T., Higashijima, Y., Wada, T., & Nangaku, M. (2014) · Kidney International · doi:10.1038/ki.2014.236 · Cited by 133
Ogawa, S., Mori, T., Nako, K., KATO, T., Takeuchi, K., & Ito, S. (2006) · Hypertension · doi:10.1161/01.hyp.0000203826.15076.4b · Cited by 132
Add-on angiotensin receptor blockade with maximized ACE inhibition
Agarwal, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00745.x · Cited by 131
Pop‐Busui, R., Herman, W. H., Feldman, E. L., Low, P. A., Martin, C. L., Cleary, P. A., Waberski, B. H., Lachin, J. M., & Albers, J. W. (2010) · Current Diabetes Reports · doi:10.1007/s11892-010-0120-8 · Cited by 129
Hypertension Control: How Well Are We Doing?
Borzecki, A. M., Wong, A. T., Hickey, E. C., Ash, A. S., & Berlowitz, D. R. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.22.2705 · Cited by 128
Fried, L. F., Duckworth, W. C., Zhang, J. H., O’Connor, T., Brophy, M. T., Emanuele, N., Huang, G. D., McCullough, P. A., Palevsky, P. M., Seliger, S. L., et al. (2008) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03350708 · Cited by 128
Unchanged Incidence of Diabetic Nephropathy in IDDM Patients
Rossing, P. R., Rossing, K., Jacobsen, P. K., & PARVING, H.-H. D. (1995) · Diabetes · doi:10.2337/diab.44.7.739 · Cited by 127
Self-citationTikoo, K., Tripathi, D. N., Kabra, D. G., Sharma, V., & Gaikwad, A. B. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.006 · Cited by 126
Stehouwer, C. D. A. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh015 · Cited by 126
ACE Inhibitors versus AT1 Receptor Antagonists in Patients with Chronic Renal Disease
Hilgers, K. F., & Mann, J. F. E. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1341100 · Cited by 126
Dasgupta, A., Steinhubl, S. R., Bhatt, D. L., Berger, P. B., Shao, M., Mak, K., Fox, K. A. A., Montalescot, G., Weber, M. A., Haffner, S. M., et al. (2009) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2009.01.342 · Cited by 125
Atubular Glomeruli and Glomerulotubular Junction Abnormalities in Diabetic Nephropathy
Najafian, B., Kim, Y., Crosson, J. T., & Mauer, M. S. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000057854.32413.81 · Cited by 125
Kelly, D. J. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.7.1327 · Cited by 125
Remission of nephrotic range proteinuria in type I diabetes
Hebert, L. A., Bain, R. P., Verme, D., Cattran, D. C., Whittier, F. C., Tolchin, N., Rohde, R. D., Lewis, E. J., Lewis, E. J., Rohde, R., et al. (1994) · Kidney International · doi:10.1038/ki.1994.469 · Cited by 124
Jennings, D. L., Kalus, J. S., Coleman, C. I., Manierski, C., & Yee, J. (2007) · Diabetic Medicine · doi:10.1111/j.1464-5491.2007.02097.x · Cited by 124
Progression to Overt Nephropathy in Type 2 Diabetes
Bruno, G., Merletti, F., Biggeri, A., Bargero, G., Ferrero, S., Pagano, G., & Perin, P. C. (2003) · Diabetes Care · doi:10.2337/diacare.26.7.2150 · Cited by 118
Bruno, G., Merletti, F., Bargero, G., Novelli, G., Melis, D., Soddu, A., Perotto, M., Pagano, G., & Cavallo‐Perin, P. (2007) · Diabetologia · doi:10.1007/s00125-007-0616-1 · Cited by 117
Impaired autoregulation of GFR in hypertensive non-insulin dependent diabetic patients
Christensen, P. K., Hansen, H. P., & Parving, H. (1997) · Kidney International · doi:10.1038/ki.1997.463 · Cited by 117
Dedifferentiation of Immortalized Human Podocytes in Response to Transforming Growth Factor-β
Herman‐Edelstein, M., Thomas, M. C., Thallas‐Bonke, V., Saleem, M. A., Cooper, M. E., & Kantharidis, P. (2011) · Diabetes · doi:10.2337/db10-1110 · Cited by 117
Self-citationHovind, P. H., Rossing, P. R., Tarnow, L., Smidt, U., & Parving, H. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00797.x · Cited by 115
Self-citationCompeting-Risk Analysis of ESRD and Death among Patients with Type 1 Diabetes and Macroalbuminuria
Forsblom, C. M., Harjutsalo, V., Thorn, L. M., Wadén, J., Tolonen, N., Saraheimo, M., Gordin, D., Moran, J. L., Thomas, M. C., & Groop, P. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010020194 · Cited by 115
Self-citationThe burden of chronic kidney disease in Australian patients with type 2 diabetes (the NEFRON study)
Thomas, M. C., Weekes, A., Broadley, O. J., Cooper, M. E., & Mathew, T. H. (2006) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2006.tb00499.x · Cited by 114
Self-citationTreatment of Cardiovascular and Renal Risk Factors in the Diabetic Hypertensive
Sowers, J. R., & Haffner, S. M. (2002) · Hypertension · doi:10.1161/01.hyp.0000042097.39655.b7 · Cited by 114
Rosiglitazone decreases albuminuria in type 2 diabetic patients
Miyazaki, Y., Cersósimo, E., Triplitt, C. L., & DeFronzo, R. A. (2007) · Kidney International · doi:10.1038/sj.ki.5002516 · Cited by 113
Cordonnier, D., Pinel, N., Barro, C. D., Maynard, C., Zaoui, P., Halimi, S., de Ligny, B. H., Reznic, Y., Simon, D., & Bilous, R. W. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1061253 · Cited by 112
Progression of chronic renal disease
Klahr, S., & Morrissey, J. J. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50074 · Cited by 111
Nymark, M., Pussinen, P. J., Tuomainen, A. M., Forsblom, C. M., Groop, P., Lehto, M. J., & on behalf of the FinnDiane Study Group (2009) · Diabetes Care · doi:10.2337/dc09-0467 · Cited by 109
Self-citationTakiyama, Y., & Haneda, M. (2014) · BioMed Research International · doi:10.1155/2014/837421 · Cited by 109
Morcos, M., Borcea, V., Isermann, B., Gehrke, S. G., Ehret, T., Henkels, M., Schiekofer, S., Hofmann, M. A., Amiral, J., Tritschler, H., et al. (2001) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(01)00223-6 · Cited by 109
A Practical Approach to Achieving Recommended Blood Pressure Goals in Diabetic Patients
Bakris, G. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.22.2661 · Cited by 108
Effect of Fenofibrate on Kidney Function: A 6-Week Randomized Crossover Trial in Healthy People
Ansquer, J.-C., Dalton, R. N., Caussé, E., Crimet, D., Le Malicot, K., & Foucher, C. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.014 · Cited by 107
Fufaa, G. D., Weil, E. J., Nelson, R. G., Hanson, R. L., Bonventre, J. V., Sabbisetti, V. S., Waikar, S. S., Mifflin, T. E., Zhang, X., Xie, D., et al. (2014) · Diabetologia · doi:10.1007/s00125-014-3389-3 · Cited by 107
Jandeleit-Dahm, K. A. M., & Cooper, M. E. (2002) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-200203000-00014 · Cited by 107
Self-citationHyperglycemia and mechanical stress: Targeting the renal podocyte
Lewko, B., & Stępiński, J. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.21856 · Cited by 105
Volpe, M., Savoia, C., Paolis, P. D., Ostrowska, B., Tarasi, D., & Rubattu, S. (2002) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000032549.36050.78 · Cited by 105
Han, D. C., Hoffman, B. B., Hong, S. W., Guo, J., & Ziyadeh, F. N. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.278.4.f628 · Cited by 105
Gilbert, R. E., Krum, H., Wilkinson‐Berka, J. L., & Kelly, D. J. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00979.x · Cited by 104
Oxidative Stress: The Lead or Supporting Actor in the Pathogenesis of Diabetic Complications
Kuroki, T., Isshiki, K., & King, G. L. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000077405.07888.07 · Cited by 103
Oral Contraceptives, Angiotensin-Dependent Renal Vasoconstriction, and Risk of Diabetic Nephropathy
Ahmed, S. B., Hovind, P. H., Parving, H., Rossing, P. R., Price, D. A., Laffel, L. M., Lansang, M. C., Stevanovic, R. D., Fisher, N. D. L., & Hollenberg, N. K. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1988 · Cited by 101
Self-citationFoley, R. N., & Hakim, R. M. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009030282 · Cited by 100
Estacio, R., Coll, J. R., Tran, Z. V., & Schrier, R. W. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2006.05.011 · Cited by 99
Bakris, G. L., Ruilope, L. M., Locatelli, F., Ptaszynska, A., Pieske, B. M., de Champlain, J., Weber, M. A., & Raz, I. (2007) · Kidney International · doi:10.1038/sj.ki.5002455 · Cited by 98
Rognant, N., Lemoine, S., Laville, M., Hadj‐Aïssa, A., & Dubourg, L. D. (2011) · Diabetes Care · doi:10.2337/dc11-0203 · Cited by 98
Kidney volume, blood pressure, and albuminuria: findings in an Australian aboriginal community
Singh, G., & Hoy, W. E. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.10.015 · Cited by 98
Grossman, E., & Messerli, F. H. (2008) · KARGER eBooks · doi:10.1159/000115189 · Cited by 97
Adamczak, M., Zeier, M., Dikow, R., & Ritz, E. (2002) · Kidney International · doi:10.1046/j.1523-1755.61.s80.28.x · Cited by 95
Fujii, M., Inoguchi, T., Maeda, Y., Sasaki, S., Sawada, F., Saito, R., Kobayashi, K., Sumimoto, H., & Takayanagi, R. (2007) · Kidney International · doi:10.1038/sj.ki.5002366 · Cited by 94
Evolution of incipient nephropathy in type 2 diabetes mellitus
Lemley, K. V., Abdullah, I., Myers, B. D., Meyer, T. W., Blouch, K. L., Smith, W. E., Bennett, P. H., & Nelson, R. G. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00223.x · Cited by 94
Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians.
Nelson, R. G., Morgenstern, H., & Bennett, P. H. (1998) · Diabetes · doi:10.2337/diabetes.47.9.1489 · Cited by 94
Tanaka, Y., Atsumi, Y., Matsuoka, K., Onuma, T., Tohjima, T., & Kawamori, R. (1998) · Diabetes Care · doi:10.2337/diacare.21.1.116 · Cited by 93
Pugliese, G., Solini, A., Fondelli, C., Trevisan, R., Vedovato, M., Nicolucci, A., & Penno, G. (2011) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfr140 · Cited by 93
Angiotensin II Blockade Restores Albumin Reabsorption in the Proximal Tubules of Diabetic Rats
Tojo, A., Onozato, M. L., Kurihara, H., Sakai, T., Goto, A., & Fujita, T. (2003) · Hypertension Research · doi:10.1291/hypres.26.413 · Cited by 92
Systolic blood pressure relates to the rate of progression of albuminuria in NIDDM
Schmitz, A., V�th, M., & Mogensen, C. E. (1994) · Diabetologia · doi:10.1007/bf00399799 · Cited by 92
Amin, A. P., Whaley‐Connell, A. T., Li, S., Chen, S., McCullough, P. A., & Kosiborod, M. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.01.005 · Cited by 92
Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes
Elley, C. R., Robinson, T., Moyes, S. A., Kenealy, T. W., Collins, J. F., Robinson, E., Orr‐Walker, B., & Drury, P. (2013) · Diabetes Care · doi:10.2337/dc13-0190 · Cited by 89
Role of Nephrin in Renal Disease Including Diabetic Nephropathy
Cooper, M. E., Mundel, P. H., & Boner, G. (2002) · Seminars in Nephrology · doi:10.1053/snep.2002.34724 · Cited by 87
Self-citationSerum Lipids and the Progression of Nephropathy in Type 1 Diabetes
Thomas, M. C., Rosengård‐Bärlund, M., Mills, V., Rönnback, M., Thomas, S., Forsblom, C. M., Cooper, M. E., Taskinen, M., Viberti, G. C., & Groop, P. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-0809 · Cited by 87
Self-citationImpact of weight change on albuminuria in the general population
Bello, A. K., de Zeeuw, D., Nahas, M. E., Brantsma, A. H., Bakker, S. J. L., de Jong, P. E., & Gansevoort, R. T. (2007) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfm091 · Cited by 86
Tuttle, K. R., & Anderson, P. W. (2003) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(03)00741-8 · Cited by 85
Regulation of Transforming Growth Factor β in Diabetic Nephropathy: Implications for Treatment
Zhu, Y., Usui, H. K., & Sharma, K. (2007) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2007.01.008 · Cited by 85
Self-citationClinical factors associated with urinary albumin excretion in type II diabetes
Savage, S., Nagel, N. J., Estacio, R. O., Lukken, N., & Schrier, R. W. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90565-0 · Cited by 84
Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H., Rossing, K., Hansen, T. W., & Rossing, P. R. (2014) · Diabetes Care · doi:10.2337/dc13-2036 · Cited by 84
Self-citationCarlsson, L. M. S., Romeo, S., Jacobson, P., Burza, M. A., Maglio, C., Sjöholm, K., Svensson, P., Haraldsson, B. S., Peltonen, M., & Sjöström, L. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.72 · Cited by 83
Reis, A., Rudnitskaya, A. M., Chariyavilaskul, P., Dhaun, N., Melville, V., Goddard, J. G., Webb, D. J., Pitt, A. R., & Spickett, C. M. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055624 · Cited by 83
Recent advances in management of type 2 diabetes and nephropathy: Lessons from the RENAAL study
Keane, W. F., & Lyle, P. A. (2003) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2003.50078 · Cited by 83
Kowluru, R. A. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990029 · Cited by 83
Círillo, M., Lombardi, C., Chiricone, D., Santo, N. G. D., Zanchetti, A., & Bilancio, G. (2014) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfu056 · Cited by 83
Genetic Variation in the Renin-Angiotensin System and Progression of Diabetic Nephropathy
Jacobsen, P. K., Tarnow, L., Carstensen, B., Hovind, P. H., Poirier, O., & Parving, H. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000092139.19587.51 · Cited by 83
Hansen, H. P., Rossing, P. R., Tarnow, L., Nielsen, F. S., Jensen, B. R., & Parving, H. (1995) · Kidney International · doi:10.1038/ki.1995.238 · Cited by 82
Self-citationAlbuminuria and Vascular Damage — The Vicious Twins
Ritz, E. (2003) · New England Journal of Medicine · doi:10.1056/nejme030066 · Cited by 82
Pimagedine: a novel therapy for diabetic nephropathy
Bolton, W. K., & Abdel‐Rahman, E. M. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.4.565 · Cited by 82
Effects of different antihypertensive drugs on human diabetic proteinuria
Weidmann, P. U., Boehlen, L., & de Courten, M. (1993) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/8.7.582 · Cited by 81
Block, G. A., Ix, J. H., Ketteler, M., Martin, K. J., Thadhani, R., Tonelli, M. A., Wolf, M. S., Jüppner, H., Hruska, K. A., & Wheeler, D. C. (2013) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2013.03.042 · Cited by 81
Lipid abnormalities predict progression of renal disease in patients with type 1 diabetes
FinnDiane Study Group, Tolonen, N., Forsblom, C. M., Thorn, L. M., Wadén, J., Rosengård‐Bärlund, M., Saraheimo, M., Feodoroff, M., Mäkinen, V., Gordin, D., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1541-2 · Cited by 80
Self-citationSerum Uric Acid as a New Player in the Development of Diabetic Nephropathy
Hovind, P. H., Rossing, P. R., Johnson, R. J., & Parving, H. (2011) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2010.10.024 · Cited by 78
Self-citationThe role of renal proximal tubular cells in diabetic nephropathy
Phillips, A. O. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0013-1 · Cited by 76
Shepherd, J., Kastelein, J. J. P., Bittner, V., Carmena, R., DEEDWANIA, P. C., Breazna, A., Dobson, S., Wilson, D. J., Zuckerman, A. L., & WENGER, N. K. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.8.870 · Cited by 75
Risks of rapid decline renal function in patients with type 2 diabetes
Sheen, Y., & Sheu, W. H. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.835 · Cited by 74
Retarding the progression of renal disease
Brenner, B. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.t01-2-00052.x · Cited by 74
Pavkov, M. E., Knowler, W. C., Bennett, P. H., Looker, H. C., Krakoff, J. A., & Nelson, R. G. (2006) · Kidney International · doi:10.1038/sj.ki.5001882 · Cited by 74
Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding
Youssef, S., Nguyen, D. T., Soulis, T., Panagiotopoulos, S., Jerums, G., & Cooper, M. E. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003907.x · Cited by 74
Self-citationMeasured GFR as “Gold Standard”—All that Glitters Is Not Gold?
Hsu, C., & Bansal, N. (2011) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.06040611 · Cited by 73
Improved prognosis of diabetic nephropathy in type 1 diabetes
Andrésdóttir, G., Jensen, M. L., Carstensen, B., Parving, H., Hovind, P. H., Hansen, T. W., & Rossing, P. R. (2014) · Kidney International · doi:10.1038/ki.2014.206 · Cited by 72
Self-citationRuggenenti, P. L., Perna, A., Ganeva, M. G., Ene‐Iordache, B., & Remuzzi, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006060560 · Cited by 70
Rationale and Strategies for Early Detection and Management of Diabetic Kidney Disease
Radbill, B. D., Murphy, B. T., & LeRoith, D. (2008) · Mayo Clinic Proceedings · doi:10.4065/83.12.1373 · Cited by 70
Weigert, C., Brodbeck, K., Brosius, F. C., Huber, M., Lehmann, R., Friess, U., Facchin, S., Aulwurm, S., Häring, H. U., Schleicher, E. D., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.2.527 · Cited by 69
Cellular and molecular mechanisms of diabetic glomerulopathy
Gnudi, L. (2012) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs121 · Cited by 69
Bianchi, C., & Prato, S. D. (2011) · The Review of Diabetic Studies · doi:10.1900/rds.2011.8.432 · Cited by 68
The importance of diabetic nephropathy in current nephrological practice
Locatelli, F. (2003) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfg288 · Cited by 68
Cited by
Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease
Thomas, M. C., Cooper, M. E., & Zimmet, P. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.173 · Cited by 742
Self-citationDiabetic vascular diseases: molecular mechanisms and therapeutic strategies
Li, Y., Liu, Y., Liu, S., Gao, M., Wang, W., Chen, K., Huang, L., & Liu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01400-z · Cited by 704
The Global Epidemiology of Diabetes and Kidney Disease
Koye, D. N., Magliano, D. J., Nelson, R. G., & Pavkov, M. E. (2018) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2017.10.011 · Cited by 686
Antar, S. A., Ashour, N. A., Sharaky, M., Khattab, M., Ashour, N. A., Zaid, R. T., Roh, E. J., Elkamhawy, A., & Al-Karmalawy, A. A. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115734 · Cited by 622
The tubular hypothesis of nephron filtration and diabetic kidney disease
Vallon, V., & Thomson, S. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0256-y · Cited by 465
Metadata
- Authors
- Thomas, M. C., Brownlee, M., Susztak, K., Sharma, K., Jandeleit-Dahm, K. A. M., Zoungas, S., Rossing, P., Groop, P.-H., & Cooper, M. E.
- Venue
- Nature Reviews Disease Primers
- Published
- 2015-07-30
- Volume
- 1
- Issue
- 1
- Pages
- 15018-15018
- ISSN
- 2056-676X (ISSN-L)
- OpenAlex
- W2394782024
- Cited by
- 1,230
- References
- 505
- FWCI
- 2.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.